We’ll be attending the annual meeting of NCPA in Kansas City, October 1 – 4. If you’re coming, let’s meet up! Our team on site will also be available at the CPESN USA booth #541 in the Exhibit Hall on Sunday, October 2, 2022 and on Monday, October 3, 2022 between 12:30 – 3:30 pm…
Fargo, ND , June 2 2022 – RxE2 announces the appointment of David Stark as Senior Director of Business Development. In his role as senior director of business development, Mr. stark will be in charge of exploring new opportunities for expansion and partnerships for RxE2. “We were looking for an individual with a wide range…
Fargo, ND, June 1, 2022 – For the second year in a row RxE2, led by CEO and two-time USA Cycling Masters National Champion, Gerald Finken, supports the NorthStar Cycling Club. “Getting young adults involved in cycling is a wonderful way to build lifelong friendships, develop teamwork skills, and to provide a means to deal…
FARGO, ND, April 15, 2021 /EINPresswire.com/ — RxE2 Inc. announced today that it has completed the acquisition of Habitu Ltd. The details of the agreement were disclosed in a press release on January 11, 2021 Here is the link to the press release with the specifics of how Habitu’s AI-powered technology platform will enhance RxE2’s…
Fargo, ND, February 2, 2021— RxE2 CEO and two-time USA Cycling Masters National Cycling Champion, Gerald Finken, is once again helping young cyclists. RxE2 announced today that it will donate $27,500 to support the youth programs of the NorthStar Development Cycling Club. Mr. Finken’s current contribution will help to support the: training of young cyclists,…
Fargo, ND, January 11, 2021 — RxE2, which is bringing the practice of pharmacy to clinical research, announced today it has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people’s habits and behaviors to create a KyP engine enabled by artificial intelligence, improving patient outcomes by providing real time analyses of a…
E2 Dispensing is part of the RxE2’s decentralized clinical trial research platform, which makes clinical trial enrollment possible for everyone, everywhere. Fargo, North Dakota, and London, UK July 29, 2020 — RxE2 and Newdays Pharmacy have launched the first pharmacy dispensing services for clinical drug trials in the European Union and the United Kingdom. This…
Fargo, ND, July 15, 2020 — RxE2 announced today the appointment of Tina Schlecht, Pharm. D. as the company’s Vice President of Pharmacy Operations. Tina Schlecht, Pharm. D., Vice President ofPharmacy Operations, RxE2 In this role, Dr. Schlecht will be responsible for: Onboarding new pharmacies worldwide to RxE2’s decentralized clinical research platform Overseeing the company’s…
E2 Dispensing, part of the RxE2’s decentralized clinical trial platform, provides an adaptable, simplified, cost effective, state pharmacy regulation abiding alternative to traditional packaging, labeling and dispensing processes. Fargo, North Dakota, June 25, 2020 — Pharma companies with drugs in clinical development can now easily, cost effectively and legally reach ALL qualifying clinical trial patients…